Optimization of Extended-Release Tacrolimus Dose with Mycophenolate Mofetil based Immunosuppression in De novo Kidney Transplant Recipients using extensive pharmacokinetics monitoring
Latest Information Update: 01 Apr 2022
At a glance
- Drugs Tacrolimus (Primary) ; Basiliximab; Mycophenolate mofetil
- Indications Renal transplant rejection
- Focus Therapeutic Use
Most Recent Events
- 01 Apr 2022 New trial record
- 28 Mar 2022 Primary endpoint has not been met. (Biopsy-proven acute allograft rejection rate after 6 months and 12 months.), as per Results published in the Clinical Transplantation
- 28 Mar 2022 Results published in the Clinical Transplantation